Format

Send to

Choose Destination
Circ Cardiovasc Interv. 2019 Oct;12(10):e008296. doi: 10.1161/CIRCINTERVENTIONS.119.008296. Epub 2019 Oct 14.

Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK Trial.

Author information

1
Sorbonne Université, ACTION (Allies in Cardiovascular Trials Initiatives and Organized Networks) Study Group, INSERM UMRS_1166, Institut de cardiologie (Assistance Publique - Hopitaux de Paris), Paris, France (M.Z., O.B., M.H.-M., P.G., G.H., P.O., D.B., N.V., M.K., J.S., J.-P.C., G.M.).
2
Statistician Unit, StatEthic, Levallois-Perret, France (S.R.).
3
ACTION Study Group, Unité de Recherche Clinique, Hôpital Lariboisière (AP-HP), Paris, France (E.V.).
4
Heart Center Leipzig, University of Leipzig, Germany (S.D., H.T.).
5
Leipzig Heart Institute, Germany (S.D., H.T.).
6
Department of Cardiology, Heart Centre Ludwigshafen, Germany (U.Z.).

KEYWORDS:

Thrombolysis in Myocardial Infarction flow; percutaneous coronary intervention; shock; shock, cardiogenic

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center